These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2763314)

  • 61. Drug interactions in biotransformation of 1-phthalidyl 5-fluorouracil to 5-fluorouracil in rat liver.
    Hirata M; Tonda K
    Chem Biol Interact; 1984 Dec; 52(2):141-50. PubMed ID: 6509684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glutathione S-transferase activity in rat pancreas.
    Black O; Howerton BK
    J Natl Cancer Inst; 1984 Jan; 72(1):121-3. PubMed ID: 6582291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of carrageenan-induced inflammation on the induction of hepatic microsomal enzymes by phenobarbital and benzo[a]pyrene in male rats.
    Ishikawa M; Sasaki K; Takayanagi Y; Sasaki K
    J Pharmacobiodyn; 1992 Apr; 15(4):139-46. PubMed ID: 1494976
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo biotransformation and biliary excretion of 1-14C-acrylonitrile in rats.
    Ghanayem BI; Ahmed AE
    Arch Toxicol; 1982 Jul; 50(2):175-85. PubMed ID: 7125911
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute toxicity of fluorinated ether anesthetics: role of 2,2,2-trifluoroethanol and other metabolites.
    Murphy MJ; Dunbar DA; Kaminsky LS
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):84-92. PubMed ID: 6138883
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circadian rhythm of the liver of male rats pre-treated with phenobarbital--II. Hexobarbital sleeping time and lipids content in liver and serum.
    Nishikawa J; Yabe T; Kast A; Albert H
    Chronobiol Int; 1987; 4(2):175-82. PubMed ID: 3508738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modulation of ascorbic acid metabolism by cytochrome P450 induction revealed by metabonomics and transcriptional profiling.
    Aranibar N; Bhaskaran V; Ott KH; Vassallo J; Nelson D; Lecureux L; Gong L; Stryker S; Lehman-McKeeman L
    Magn Reson Chem; 2009 Dec; 47 Suppl 1():S12-9. PubMed ID: 19768707
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of drug and chemical pretreatments on biliary excretion of phenylcyclohexene in the rat.
    Law FC; Chakrabarti S
    Drug Chem Toxicol; 1984; 7(3):273-82. PubMed ID: 6734467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Perturbation of calcium homeostasis by CCl4 in rats pretreated with chlordecone and phenobarbital.
    Agarwal AK; Mehendale HM
    Environ Health Perspect; 1984 Aug; 57():289-91. PubMed ID: 6209127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inactivation of cytochrome P-450 by the drug methoxsalen.
    Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
    J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of the effects of musk ketone on mouse hepatic cytochrome P450 enzymes.
    Stuard SB; Caudill D; Lehman-McKeeman LD
    Fundam Appl Toxicol; 1997 Dec; 40(2):264-71. PubMed ID: 9441723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
    Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
    Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
    Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases.
    Ghanayem BI; Burka LT; Matthews HB
    J Pharmacol Exp Ther; 1987 Jul; 242(1):222-31. PubMed ID: 3612528
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of dietary fat on the induction of hepatic microsomal cytochrome P450 isozymes by phenobarbital.
    Kim HJ; Choi ES; Wade AE
    Biochem Pharmacol; 1990 May; 39(9):1423-30. PubMed ID: 2334442
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes.
    Surendradoss J; Chang TK; Abbott FS
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):413-22. PubMed ID: 22940460
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
    Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
    J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.